215 related articles for article (PubMed ID: 24291866)
21. Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis.
Seminary ER; Santarriaga S; Wheeler L; Mejaki M; Abrudan J; Demos W; Zimmermann MT; Urrutia RA; Fee D; Barkhaus PE; Ebert AD
Cells; 2020 Feb; 9(3):. PubMed ID: 32121108
[TBL] [Abstract][Full Text] [Related]
22. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons.
Ratti A; Gumina V; Lenzi P; Bossolasco P; Fulceri F; Volpe C; Bardelli D; Pregnolato F; Maraschi A; Fornai F; Silani V; Colombrita C
Neurobiol Dis; 2020 Nov; 145():105051. PubMed ID: 32827688
[TBL] [Abstract][Full Text] [Related]
23. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons.
Subramanian V; Crabtree B; Acharya KR
Hum Mol Genet; 2008 Jan; 17(1):130-49. PubMed ID: 17916583
[TBL] [Abstract][Full Text] [Related]
24. Modeling ALS using iPSCs: is it possible to reproduce the phenotypic variations observed in patients
Vasques JF; Mendez-Otero R; Gubert F
Regen Med; 2020 Jul; 15(7):1919-1933. PubMed ID: 32795164
[TBL] [Abstract][Full Text] [Related]
25. Patient-Specific Cells for Modeling and Decoding Amyotrophic Lateral Sclerosis: Advances and Challenges.
Zhao A; Pan Y; Cai S
Stem Cell Rev Rep; 2020 Jun; 16(3):482-502. PubMed ID: 31916190
[TBL] [Abstract][Full Text] [Related]
26. ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation.
Hor JH; Santosa MM; Lim VJW; Ho BX; Taylor A; Khong ZJ; Ravits J; Fan Y; Liou YC; Soh BS; Ng SY
Cell Death Differ; 2021 Apr; 28(4):1379-1397. PubMed ID: 33184465
[TBL] [Abstract][Full Text] [Related]
27. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons.
Osaki T; Uzel SGM; Kamm RD
Sci Adv; 2018 Oct; 4(10):eaat5847. PubMed ID: 30324134
[TBL] [Abstract][Full Text] [Related]
28. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo.
Qian K; Huang H; Peterson A; Hu B; Maragakis NJ; Ming GL; Chen H; Zhang SC
Stem Cell Reports; 2017 Apr; 8(4):843-855. PubMed ID: 28366455
[TBL] [Abstract][Full Text] [Related]
29. Generation and optimization of highly pure motor neurons from human induced pluripotent stem cells via lentiviral delivery of transcription factors.
Sepehrimanesh M; Ding B
Am J Physiol Cell Physiol; 2020 Oct; 319(4):C771-C780. PubMed ID: 32783653
[TBL] [Abstract][Full Text] [Related]
30. Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis.
Muzio L; Sirtori R; Gornati D; Eleuteri S; Fossaghi A; Brancaccio D; Manzoni L; Ottoboni L; Feo L; Quattrini A; Mastrangelo E; Sorrentino L; Scalone E; Comi G; Marinelli L; Riva N; Milani M; Seneci P; Martino G
Nat Commun; 2020 Jul; 11(1):3848. PubMed ID: 32737286
[TBL] [Abstract][Full Text] [Related]
31. Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".
Bilican B; Serio A; Barmada SJ; Nishimura AL; Sullivan GJ; Carrasco M; Phatnani HP; Puddifoot CA; Story D; Fletcher J; Park IH; Friedman BA; Daley GQ; Wyllie DJ; Hardingham GE; Wilmut I; Finkbeiner S; Maniatis T; Shaw CE; Chandran S
Sci Transl Med; 2013 Jun; 5(188):188le2. PubMed ID: 23740897
[TBL] [Abstract][Full Text] [Related]
32. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
[TBL] [Abstract][Full Text] [Related]
33. Damaged DNA Is an Early Event of Neurodegeneration in Induced Pluripotent Stem Cell-Derived Motoneurons with UBQLN2
Zhang Y; Zeng B; Gu A; Kang Q; Zhao M; Peng G; Zhou M; Liu W; Liu M; Ding L; Liang D; Liu X; Liu M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232630
[No Abstract] [Full Text] [Related]
34. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells.
Li Q; Feng Y; Xue Y; Zhan X; Fu Y; Gui G; Zhou W; Richard JP; Taga A; Li P; Mao X; Maragakis NJ; Ying M
Mol Neurodegener; 2022 Jan; 17(1):8. PubMed ID: 35012575
[TBL] [Abstract][Full Text] [Related]
35. Reprogramming fibroblasts and peripheral blood cells from a C9ORF72 patient: A proof-of-principle study.
Bardelli D; Sassone F; Colombrita C; Volpe C; Gumina V; Peverelli S; Catusi I; Ratti A; Silani V; Bossolasco P
J Cell Mol Med; 2020 Apr; 24(7):4051-4060. PubMed ID: 32125773
[TBL] [Abstract][Full Text] [Related]
36. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
37. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
38. [Generation of induced pluripotent stem cells from amyotrophic lateral sclerosis patientcarrying SOD1-V14M mutation].
Liu X; Chen J; Li X; Gao S; Deng M
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(27):2143-7. PubMed ID: 25327864
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs.
Jin M; Akgün K; Ziemssen T; Kipp M; Günther R; Hermann A
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360808
[TBL] [Abstract][Full Text] [Related]
40. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS.
Park JH; Park HS; Hong S; Kang S
Exp Mol Med; 2016 Dec; 48(12):e276. PubMed ID: 27932790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
